Literature DB >> 12957095

Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries.

Monika L Metzger1, Scott C Howard, Ligia C Fu, Armando Peña, Rene Stefan, Michael L Hancock, Zhe Zhang, Ching Hon Pui, Judy Wilimas, Raul C Ribeiro.   

Abstract

The causes of treatment failure in childhood acute lymphoblastic leukaemia are thought to differ between resource-rich and resource-poor countries. We assessed the records of 168 patients treated for this disease in Honduras. Abandonment of treatment (n=38), the main cause of failure, was associated with prolonged travel time to the treatment facility (2-5 h: hazard ratio 3.1, 95% CI 1.2-8.1 vs >5 h: 3.7, 1.3-10.9) and age younger than 4.5 years (2.6, 1.1-6.3). 35 patients died of treatment-related effects. Outcome could be substantially improved by interventions that help to prevent abandonment of therapy (such as funding for transport, satellite clinics, and support groups), and by prompt treatment of infection.

Entities:  

Mesh:

Year:  2003        PMID: 12957095     DOI: 10.1016/S0140-6736(03)14228-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  27 in total

Review 1.  International collaboration on childhood leukemia.

Authors:  Ching-Hon Pui; Raul C Ribeiro
Journal:  Int J Hematol       Date:  2003-12       Impact factor: 2.490

2.  Care of pediatric cancers in the developing world: should this be a societal priority?

Authors:  Maurie Markman
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.075

3.  Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study.

Authors:  Raul C Ribeiro; Eva Steliarova-Foucher; Ian Magrath; Jean Lemerle; Tim Eden; Caty Forget; Isabel Mortara; Isabelle Tabah-Fisch; Jose Julio Divino; Thomas Miklavec; Scott C Howard; Franco Cavalli
Journal:  Lancet Oncol       Date:  2008-08       Impact factor: 41.316

4.  Incidence and consequences of varicella in children treated for cancer in Guatemala.

Authors:  Amy E Caruso Brown; Edwin J Asturias; Mario Melgar; Federico A Antillon-Klussmann; Pamela Mettler; Myron J Levin
Journal:  World J Pediatr       Date:  2016-06-29       Impact factor: 2.764

Review 5.  Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.

Authors:  Allen E J Yeoh; Daryl Tan; Chi-Kong Li; Hiroki Hori; Eric Tse; Ching-Hon Pui
Journal:  Lancet Oncol       Date:  2013-11       Impact factor: 41.316

6.  Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: Findings from the CONCORD-2 study.

Authors:  Eric W Tai; Kevin C Ward; Audrey Bonaventure; David A Siegel; Michel P Coleman
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

7.  Interventions targeting absences increase adherence and reduce abandonment of childhood cancer treatment in El Salvador.

Authors:  Carmen Salaverria; Nuria Rossell; Angelica Hernandez; Soad Fuentes Alabi; Roberto Vasquez; Miguel Bonilla; Catherine G Lam; Raul C Ribeiro
Journal:  Pediatr Blood Cancer       Date:  2015-04-29       Impact factor: 3.167

8.  Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia.

Authors:  Karen R Rabin; M Monica Gramatges; Michael J Borowitz; Shana L Palla; Xiaodong Shi; Judith F Margolin; Patrick A Zweidler-McKay
Journal:  Pediatr Blood Cancer       Date:  2011-11-18       Impact factor: 3.167

9.  Pediatric sarcoma in Central America: outcomes, challenges, and plans for improvement.

Authors:  Paola Friedrich; Roberta Ortiz; Kelly Strait; Soad Fuentes; Yéssica Gamboa; Ingrid Arambú; María Ah-Chu-Sanchez; Wendy London; Carlos Rodríguez-Galindo; Federico Antillón-Klussmann; Fulgencio Báez
Journal:  Cancer       Date:  2012-09-12       Impact factor: 6.860

10.  Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis.

Authors:  William A Wood; Ruta Brazauskas; Zhen-Huan Hu; Hisham Abdel-Azim; Ibrahim A Ahmed; Mahmoud Aljurf; Sherif Badawy; Amer Beitinjaneh; Biju George; David Buchbinder; Jan Cerny; Laurence Dedeken; Miguel Angel Diaz; Cesar O Freytes; Siddhartha Ganguly; Usama Gergis; David Gomez Almaguer; Ashish Gupta; Gregory Hale; Shahrukh K Hashmi; Yoshihiro Inamoto; Rammurti T Kamble; Kehinde Adekola; Tamila Kindwall-Keller; Jennifer Knight; Lalit Kumar; Yachiyo Kuwatsuka; Jason Law; Hillard M Lazarus; Charles LeMaistre; Richard F Olsson; Michael A Pulsipher; Bipin N Savani; Kirk R Schultz; Ayman A Saad; Matthew Seftel; Sachiko Seo; Thomas C Shea; Amir Steinberg; Keith Sullivan; David Szwajcer; Baldeep Wirk; Jean Yared; Agnes Yong; Jignesh Dalal; Theresa Hahn; Nandita Khera; Carmem Bonfim; Yoshiko Atsuta; Wael Saber
Journal:  Biol Blood Marrow Transplant       Date:  2018-03-19       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.